Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.

Journal: AIDS (London, England)

Volume: 35

Issue: 7

Year of Publication: 2021

Affiliated Institutions:  HIV Mental Health Research Unit, Department of Psychiatry and Mental Health, Neuroscience Institute, Cape Town, South Africa. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg. Department of Infectious Disease, Imperial College London.

Abstract summary 

Authors & Co-authors:  Nightingale Sam S Dreyer Anna J AJ Gisslén Magnus M Winston Alan A Joska John A JA

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Rourke SB, Bekele T, Rachlis A, Kovacs C, Brunetta J, Gill MJ, et al. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period . AIDS 2021; 35:63–72.
Authors :  5
Identifiers
Doi : 10.1097/QAD.0000000000002848
SSN : 1473-5571
Study Population
Male,Female
Mesh Terms
AIDS Dementia Complex
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England